Citation Impact

Citing Papers

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
2008 Standout
Transforming Growth Factor-β Signaling–Deficient Fibroblasts Enhance Hepatocyte Growth Factor Signaling in Mammary Carcinoma Cells to Promote Scattering and Invasion
2008
Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
2011
Blockade of Hedgehog Signaling Inhibits Pancreatic Cancer Invasion and Metastases: A New Paradigm for Combination Therapy in Solid Cancers
2007
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
2010 StandoutNobel
Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition
2013
Hallmarks of Cancer: The Next Generation
2011 Standout
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Stromal biology of pancreatic cancer
2007
EGFR Antagonists in Cancer Treatment
2008 Standout
The RNA Binding Protein Quaking Regulates Formation of circRNAs
2015 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
2009 Standout
Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells
2007
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Vascular endothelial growth factor receptor‐1 in human cancer
2010
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Metastasis: a question of life or death
2006
Epithelial–mesenchymal plasticity in carcinoma metastasis
2013
Cancer Metastasis: Building a Framework
2006 Standout
Lung Cancer
2008 Standout
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
2015 StandoutNature
Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells
2009
QGP-1 cells release 5-HT via TRPA1 activation; a model of human enterochromaffin cells
2009
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Evolution and clinical translation of drug delivery nanomaterials
2017
Targeting cancer-initiating cell drug-resistance: a roadmap to a new-generation of cancer therapies?
2011
ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading
2010
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Cancer invasion and resistance: interconnected processes of disease progression and therapy failure
2011
Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content
2007
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
STAT3-iNOS Signaling Mediates EGFRvIII-Induced Glial Proliferation and Transformation
2012
Primary and acquired resistance to anti-EGFR targeted drugs in cancer therapy
2007
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Emerging Biological Principles of Metastasis
2017 Standout
EMT: 2016
2016 Standout
Update on the treatment of neuroendocrine tumors
2003
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
2011 Standout
Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells
2007
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis
2016
Pancreatic Cancer
2010 Standout
Vascular endothelial growth factor-A stimulates Snail expression in breast tumor cells: Implications for tumor progression
2008
Clonal evolution in cancer
2012 StandoutNature
A Cell-Based Small Molecule Screening Method for Identifying Inhibitors of Epithelial-Mesenchymal Transition in Carcinoma
2012
Ingression of primary mesenchyme cells of the sea urchin embryo: A precisely timed epithelial mesenchymal transition
2007
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Idiopathic pulmonary fibrosis
2011 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Predicting the outcome of chemotherapy for lung cancer
2006
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Lysosome-targeting chimaeras for degradation of extracellular proteins
2020 StandoutNatureNobel
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Tumor Angiogenesis
2008 Standout
Telomerase and cancer therapeutics
2008
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
2008 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Early events in cell adhesion and polarity during epithelial-mesenchymal transition
2012
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Overexpression of Snail induces epithelial–mesenchymal transition and a cancer stem cell–like phenotype in human colorectal cancer cells
2012
Transferrin receptor 1 in cancer: a new sight for cancer therapy.
2018
Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells
2007
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Targeted therapies in control of EMT in carcinoma and fibrosis
2007
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
RelB/p52 NF-κB Complexes Rescue an Early Delay in Mammary Gland Development in Transgenic Mice with Targeted Superrepressor IκB-α Expression and Promote Carcinogenesis of the Mammary Gland
2005
Implications of B7-H1 Expression in Clear Cell Carcinoma of the Kidney for Prognostication and Therapy
2007
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
2009
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Cancer Genome Landscapes
2013 StandoutScience
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
Preparing the “Soil”: The Premetastatic Niche
2006
Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition
2009
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
2007

Works of E. Ramsay Camp being referenced

Targeting of Urokinase Plasminogen Activator Receptor in Human Pancreatic Carcinoma Cells Inhibits c-Met– and Insulin-like Growth Factor-I Receptor–Mediated Migration and Invasion and Orthotopic Tumor Growth in Mice
2005
Hepatic Artery Embolization for Control of Symptoms, Octreotide Requirements, and Tumor Progression in Metastatic Carcinoid Tumors
2002
RON, a Tyrosine Kinase Receptor Involved in Tumor Progression and Metastasis
2005
Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy
2013
Targeting of Insulin-like Growth Factor-I Receptor with a Monoclonal Antibody Inhibits Growth of Hepatic Metastases from Human Colon Carcinoma in Mice
2007
The role of nitric oxide in mediating tumour blood flow
2006
Novel Immunocompetent Murine Models Representing Advanced Local and Metastatic Pancreatic Cancer
2011
Improving delivery of antineoplastic agents with anti‐vascular endothelial growth factor therapy
2005
Inhibition of NF-Kappa B augments sensitivity to 5-Fluorouracil/Folinic acid in colon cancer1
2004
Vascular Endothelial Growth Factor Receptor-1 Activation Mediates Epithelial to Mesenchymal Transition in Human Pancreatic Carcinoma Cells
2006
Roles of Nitric Oxide Synthase Inhibition and Vascular Endothelial Growth Factor Receptor-2 Inhibition on Vascular Morphology and Function in anIn vivoModel of Pancreatic Cancer
2006
Molecular Mechanisms of Resistance to Therapies Targeting the Epidermal Growth Factor Receptor
2005
The Development and Characterization of a Human Midgut Carcinoid Cell Line
2007
Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines
2006
Rankless by CCL
2026